DK1965763T3 - Stabile enzympræparater og fremgangsmåder til anvendelse heraf - Google Patents

Stabile enzympræparater og fremgangsmåder til anvendelse heraf Download PDF

Info

Publication number
DK1965763T3
DK1965763T3 DK06821673.8T DK06821673T DK1965763T3 DK 1965763 T3 DK1965763 T3 DK 1965763T3 DK 06821673 T DK06821673 T DK 06821673T DK 1965763 T3 DK1965763 T3 DK 1965763T3
Authority
DK
Denmark
Prior art keywords
enzym
preparations
stable
methods
stable enzym
Prior art date
Application number
DK06821673.8T
Other languages
English (en)
Inventor
Amihay Freeman
Noa Hadar
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of DK1965763T3 publication Critical patent/DK1965763T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
DK06821673.8T 2005-12-27 2006-12-27 Stabile enzympræparater og fremgangsmåder til anvendelse heraf DK1965763T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340005P 2005-12-27 2005-12-27
PCT/IL2006/001492 WO2007074454A2 (en) 2005-12-27 2006-12-27 Stable enzymatic preparations and methods of use thereof

Publications (1)

Publication Number Publication Date
DK1965763T3 true DK1965763T3 (da) 2020-02-10

Family

ID=37943776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06821673.8T DK1965763T3 (da) 2005-12-27 2006-12-27 Stabile enzympræparater og fremgangsmåder til anvendelse heraf

Country Status (6)

Country Link
US (2) US8197808B2 (da)
EP (1) EP1965763B1 (da)
JP (1) JP5435955B2 (da)
DK (1) DK1965763T3 (da)
ES (1) ES2763724T3 (da)
WO (1) WO2007074454A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
JP5435955B2 (ja) 2005-12-27 2014-03-05 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 安定な酵素製剤及びその使用方法
CA2671904C (en) * 2006-12-06 2012-07-03 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
CA2727432C (en) * 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
ES2668909T3 (es) 2009-01-06 2018-05-23 Galenagen, Llc Composiciones que comprenden proteasa, amilasa y lipasa para su uso en el tratamiento de infecciones por Staphylococcus aureus
EP2226382A1 (en) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease for wound conditioning and skin care
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011022491A1 (en) * 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
WO2012030653A2 (en) 2010-08-29 2012-03-08 Vascode Technologies Ltd. A system and methods for multi-tasking in a clientless mobile phone
ES2804223T3 (es) 2011-04-21 2021-02-04 Curemark Llc Compuestos para el tratamiento de Trastornos Neuropsiquiátricos
CN103747814B (zh) * 2011-08-31 2017-11-28 凯希特许有限公司 减压治疗与清创系统以及方法
WO2013116732A1 (en) * 2012-02-02 2013-08-08 Curelon Llc Enzyme compositions and use thereof for wound healing
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11364286B2 (en) * 2015-10-14 2022-06-21 Newsouth Innovations Pty Limited Compositions and methods for the treatment of diseases involving mucin
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB913203A (en) 1958-12-30 1962-12-19 Swift & Co Enzyme formulations for the production of tenderized meat
US3539451A (en) * 1968-05-31 1970-11-10 Castle & Cooke Production of reversibly inactivated papain and ficin
US4307081A (en) * 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4715899A (en) * 1982-10-21 1987-12-29 Subir Chanda Liquid cleaner containing inactivated protease for protein soiled contact lenses
JPH0449299A (ja) 1990-06-14 1992-02-18 Tosoh Corp 免疫グロブリンフラグメントの精製法
DE4026591B4 (de) 1990-08-23 2005-08-25 Pleva Gmbh Vorrichtung zur Bestimmung der Beladung von Luft mit Dämpfen
JP2665639B2 (ja) 1992-01-09 1997-10-22 テーオー食品株式会社 安定化されたチオール蛋白分解酵素を含む焼き肉のタレ
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
CN1612723A (zh) 2001-11-13 2005-05-04 宝洁公司 包含由抑制剂稳定化的酶的局部组合物
US6692726B1 (en) * 2003-02-11 2004-02-17 Colgate Palmolive Company Enzyme containing oral composition having enhanced stability
EA200600745A1 (ru) 2003-10-10 2006-10-27 Космедикал Апс Ингибирование роста волос
JP5435955B2 (ja) 2005-12-27 2014-03-05 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 安定な酵素製剤及びその使用方法

Also Published As

Publication number Publication date
US20090220483A1 (en) 2009-09-03
EP1965763B1 (en) 2019-11-06
WO2007074454A2 (en) 2007-07-05
JP5435955B2 (ja) 2014-03-05
US8197808B2 (en) 2012-06-12
US8337837B2 (en) 2012-12-25
WO2007074454A3 (en) 2007-09-20
JP2009521521A (ja) 2009-06-04
ES2763724T3 (es) 2020-05-29
EP1965763A2 (en) 2008-09-10
US20120114631A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
DK1965763T3 (da) Stabile enzympræparater og fremgangsmåder til anvendelse heraf
NO2017017I1 (no) umeklinidium og vilanterol
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1877090T3 (da) Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1844155T3 (da) Sekvensspecifikke serinrekombinaser og fremgangsmåder til anvendelse deraf
IS8204A (is) Tæki og aðferð til að hluta niður
DK1890588T3 (da) Ambulant lægemiddelindretning og fremgangsmåde til kommunikation mellem lægemiddelindretninger
DK1934179T3 (da) Fremgangsmåder og mellemprodukter
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
DK1984344T3 (da) Multicykliske aminosyrederivater og fremgangsmåder til anvendelse heraf
DK1929297T3 (da) Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf
DK2578685T3 (da) Rna indeholende modificerede nukleosider og fremgangsmåder til anvendelse deraf
DK1997291T3 (da) Metode og anordning til sikker godkendelse
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
DK1846445T3 (da) PYY-agonister og anvendelser deraf
DK2390267T3 (da) Stabile og opløselige antistoffer, der hæmmer TNF(alfa)
DK1919514T3 (da) Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK1817055T3 (da) Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf